- Home
- App-Analyse
- BioViewer
- BioViewer Vs. Molecules
BioViewer im Vergleich zu Molecules Nutzung und Statistiken
A .pdb protein visualizer for iOS, iPadOS and macOS. View the 3D representation of any molecular structure from a .pdb file, using our custom Metal-based rendering engine based to allow for a smooth experience even in the biggest proteins.
- Full drag and drop support for .pdb and .xyz files.
- Photo Mode with publication-quality exports.
- Support for multi-model PDBs.
- Support for high refresh rate ProMotion displays.
- Apple App Store
- Kostenlos
- Bildung
Rang speichern
- -
Molecules is an application for viewing three-dimensional renderings of molecules and manipulating them using your fingers. You can rotate the molecules by moving your finger across the display, zoom in or out by using two-finger pinch gestures, or pan the molecule by moving two fingers across the screen at once. These structures can be viewed in both ball-and-stick and spacefilling visualization modes.
Molecules can be stored on your handheld device for later viewing and are loaded via a standard document-based file browser.
Custom molecular structures can be downloaded to the application via file sharing or iCloud, and obtained via sources like the RCSB Protein Data Bank (http://www.rcsb.org/pdb), an international repository of biological molecules and their 3-D structures, or NCBI's PubChem (http://pubchem.ncbi.nlm.nih.gov), a public database of compounds. For more details, please visit our website.
Molecules is a BSD-licensed open source project.
- Apple App Store
- Kostenlos
- Bildung
Rang speichern
- -
BioViewervs. Molecules Ranking-Vergleich
Vergleichen Sie BioViewer den Ranking-Trend der letzten 28 Tage mit Molecules
Rang
Keine Daten verfügbar
BioViewer im Vergleich zu Molecules Ranking im Ländervergleich
Vergleichen Sie BioViewer den Ranking-Trend der letzten 28 Tage mit Molecules
Keine Daten zum Anzeigen
Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an
BioViewer VS.
Molecules
Dezember 15, 2024